A M M Boers1,2,3, R Sales Barros4, I G H Jansen4,2, O A Berkhemer2, L F M Beenen2, B K Menon5, D W J Dippel6, A van der Lugt7, W H van Zwam8, Y B W E M Roos9, R J van Oostenbrugge10, C H Slump3,11, C B L M Majoie2, H A Marquering4,2. 1. From the Departments of Biomedical Engineering and Physics (A.M.M.B., R.S.B., I.G.H.J., H.A.M.) amm.boers@gmail.com. 2. Radiology and Nuclear Medicine (A.M.M.B., I.G.H.J., O.A.B., L.F.M.B., C.B.L.M.M., H.A.M.). 3. Department of Robotics and Mechatronics (A.M.M.B., C.H.S.). 4. From the Departments of Biomedical Engineering and Physics (A.M.M.B., R.S.B., I.G.H.J., H.A.M.). 5. Department of Clinical Neurosciences (B.K.M.), Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Foothills Hospital, Calgary, Alberta, Canada. 6. Departments of Neurology (D.W.J.D.). 7. Radiology (A.v.d.L.), Erasmus MC, Rotterdam, the Netherlands. 8. Department of Radiology (W.H.v.Z.), Maastricht UMC, Maastricht, the Netherlands. 9. Neurology (Y.B.W.E.M.R.), Academic Medical Center, Amsterdam, the Netherlands. 10. Department of Neurology (R.J.v.O.), Maastricht UMC and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands. 11. MIRA Institute for Biomedical Engineering and Technical Medicine (C.H.S.), University of Twente, Enschede, the Netherlands.
Abstract
BACKGROUND AND PURPOSE: Many studies have emphasized the relevance of collateral flow in patients presenting with acute ischemic stroke. Our aim was to evaluate the relationship of the quantitative collateral score on baseline CTA with the outcome of patients with acute ischemic stroke and test whether the timing of the CTA acquisition influences this relationship. MATERIALS AND METHODS: From the Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands (MR CLEAN) data base, all baseline thin-slice CTA images of patients with acute ischemic stroke with intracranial large-vessel occlusion were retrospectively collected. The quantitative collateral score was calculated as the ratio of the vascular appearance of both hemispheres and was compared with the visual collateral score. Primary outcomes were 90-day mRS score and follow-up infarct volume. The relation with outcome and the association with treatment effect were estimated. The influence of the CTA acquisition phase on the relation of collateral scores with outcome was determined. RESULTS: A total of 442 patients were included. The quantitative collateral score strongly correlated with the visual collateral score (ρ = 0.75) and was an independent predictor of mRS (adjusted odds ratio = 0.81; 95% CI, .77-.86) and follow-up infarct volume (exponent β = 0.88; P < .001) per 10% increase. The quantitative collateral score showed areas under the curve of 0.71 and 0.69 for predicting functional independence (mRS 0-2) and follow-up infarct volume of >90 mL, respectively. We found significant interaction of the quantitative collateral score with the endovascular therapy effect in unadjusted analysis on the full ordinal mRS scale (P = .048) and on functional independence (P = .049). Modification of the quantitative collateral score by acquisition phase on outcome was significant (mRS: P = .004; follow-up infarct volume: P < .001) in adjusted analysis. CONCLUSIONS: Automated quantitative collateral scoring in patients with acute ischemic stroke is a reliable and user-independent measure of the collateral capacity on baseline CTA and has the potential to augment the triage of patients with acute stroke for endovascular therapy.
BACKGROUND AND PURPOSE: Many studies have emphasized the relevance of collateral flow in patients presenting with acute ischemic stroke. Our aim was to evaluate the relationship of the quantitative collateral score on baseline CTA with the outcome of patients with acute ischemic stroke and test whether the timing of the CTA acquisition influences this relationship. MATERIALS AND METHODS: From the Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands (MR CLEAN) data base, all baseline thin-slice CTA images of patients with acute ischemic stroke with intracranial large-vessel occlusion were retrospectively collected. The quantitative collateral score was calculated as the ratio of the vascular appearance of both hemispheres and was compared with the visual collateral score. Primary outcomes were 90-day mRS score and follow-up infarct volume. The relation with outcome and the association with treatment effect were estimated. The influence of the CTA acquisition phase on the relation of collateral scores with outcome was determined. RESULTS: A total of 442 patients were included. The quantitative collateral score strongly correlated with the visual collateral score (ρ = 0.75) and was an independent predictor of mRS (adjusted odds ratio = 0.81; 95% CI, .77-.86) and follow-up infarct volume (exponent β = 0.88; P < .001) per 10% increase. The quantitative collateral score showed areas under the curve of 0.71 and 0.69 for predicting functional independence (mRS 0-2) and follow-up infarct volume of >90 mL, respectively. We found significant interaction of the quantitative collateral score with the endovascular therapy effect in unadjusted analysis on the full ordinal mRS scale (P = .048) and on functional independence (P = .049). Modification of the quantitative collateral score by acquisition phase on outcome was significant (mRS: P = .004; follow-up infarct volume: P < .001) in adjusted analysis. CONCLUSIONS: Automated quantitative collateral scoring in patients with acute ischemic stroke is a reliable and user-independent measure of the collateral capacity on baseline CTA and has the potential to augment the triage of patients with acute stroke for endovascular therapy.
Authors: Lennard Wolff; Jiahang Su; Derek Van Loon; Adriaan van Es; Pieter Jan van Doormaal; Charles Majoie; Wim van Zwam; Diederik Dippel; Aad van der Lugt; Theo van Walsum Journal: Neuroradiology Date: 2022-05-24 Impact factor: 2.804
Authors: Simone M Uniken Venema; Lennard Wolff; Sophie A van den Berg; Hendrik Reinink; Sven P R Luijten; Hester F Lingsma; Henk A Marquering; Anna M M Boers; Joost Bot; Sebastiaan Hammer; Paul J Nederkoorn; Yvo B W E M Roos; Charles B L M Majoie; Jan Willem Dankbaar; Aad van der Lugt; H Bart van der Worp Journal: Neurology Date: 2022-08-02 Impact factor: 11.800
Authors: Wenjin Yang; Jazba Soomro; Ivo G H Jansen; Aashish Venkatesh; Albert J Yoo; Demetrius Lopes; Ludo F M Beenen; Bart J Emmer; Charles B L M Majoie; Henk A Marquering Journal: Clin Neuroradiol Date: 2022-09-26 Impact factor: 3.156
Authors: Daniel Guisado-Alonso; Pol Camps-Renom; Raquel Delgado-Mederos; Esther Granell; Luis Prats-Sánchez; Alejandro Martínez-Domeño; Marina Guasch-Jiménez; M Victoria Acosta; Anna Ramos-Pachón; Joan Martí-Fàbregas Journal: Front Neurol Date: 2022-08-09 Impact factor: 4.086